These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29437030)

  • 1. Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-
    Cheki M; Papie M; Mansi L; Kitson S; Gali H
    Curr Radiopharm; 2018; 11(1):58-63. PubMed ID: 29437030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
    Pathuri G; Sahoo K; Awasthi V; Gali H
    Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
    Stabin M; Taylor A; Eshima D; Wooter W
    J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary radiation dosimetry of a novel PET radiopharmaceutical
    Cheki M; Gali H
    Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
    Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
    J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
    Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
    Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vivo evaluation of ortho-[(124)I]iodohippurate for PET renography in healthy rats.
    Pathuri G; Hedrick AF; Awasthi V; Cowley BD; Gali H
    Appl Radiat Isot; 2016 Sep; 115():251-255. PubMed ID: 27434486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum sample times for single-injection, multisample renal clearance methods.
    Russell CD
    J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parametric representation of kidney function using 99mTc-mercaptoacetyltriglycine (MAG3)].
    Szabó Z; Kutkuhn B; Georgescu G; Mecklenbeck W; Suatmadji A; Vosberg H
    Nuklearmedizin; 1989 Jun; 28(3):73-83. PubMed ID: 2525703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of [¹⁸F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease.
    Pathuri G; Hedrick AF; Awasthi V; Cowley BD; Gali H
    Nucl Med Biol; 2016 Jan; 43(1):1-5. PubMed ID: 26702780
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.